spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  shingles 

 HSMN NewsFeed - 24 May 2024
YS Biopharma Announces Name Change to LakeShore Biopharma
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 14 Nov 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2016
Sorrento Therapeutics Closes Acquisition of Scilex
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jun 2016
ContraVir Completes Merger with Ciclofilin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2016
Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2016
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Mar 2013
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 May 2012
Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2012
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2011
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2011
Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 11 Aug 2010
Wound Management Technologies, Inc. Announces Business Expansion into South Africa with EWA Government Systems, Inc.
Devices Wound Care
 HSMN NewsFeed - 15 Jul 2010
Wound Management Technologies, Inc. Expands Distribution Channel into Five Central American Countries
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 4 Jun 2010
Mylan Receives Approval for Generic Version of Neurontin(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Apr 2010
Wound Management Technologies, Inc. Announces Collaboration Project for Diabetic Disease Management
Devices Wound Care
 HSMN NewsFeed - 6 Apr 2010
Wound Management Technologies, Inc. Expands Sales Management to Address Rapid National and International Business Development
Devices Wound Care Personnel
 HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2010
Barry Buckland Joins Ancora Pharmaceuticals Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2010
EpiCept Receives Orphan Drug Designation for EpiCept NP-1 in U.S.
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 May 2009
DARA BioSciences Announces Positive Trial Results of KRN5500 for Treatment of Neuropathic Pain in Patients With Cancer
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2009
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Mar 2009
Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Oct 2008
NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 May 2008
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2008
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
NeurogesX' NGX-4010 MAA Filed and Accepted for Review by EMEA for Treatment of Peripheral Neuropathic Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 20 Sep 2007
Shareholders Approve Inhibitex Acquisition of FermaVir
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Sep 2007
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 13 Aug 2007
Avigen Initiates U.S. Clinical Development for AV411
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2007
NeurogesX Completes Enrollment in Phase 3 Clinical Trial for Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2007
NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2007
Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2007
EpiCept Initiates Two Phase IIb Trials with NP-1
Biopharmaceuticals
 HSMN NewsFeed - 15 Mar 2007
Epiphany Biosciences Raises $36 Million Round in Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Feb 2007
Valtrex (valacyclovir) - US Patent Litigation Update
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jan 2007
Endo Pharmaceuticals Receives Subpoena From U.S. Department of Health and Human Services
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2007
DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Dec 2006
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
Biopharmaceuticals Drug Delivery Generics FDA
 HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
WellPoint to Cover Varicella Zoster Virus, or Shingles Vaccine
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 18 Oct 2006
NeurogesX Phase 3 Study in Post-Herpetic Neuralgia Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2006
Endo Pharmaceuticals Comments on Lidoderm(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Sep 2006
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2006
EpiCept Announces Results of European Phase III Trial for LidoPAIN(R) SP
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Jul 2006
Medivir: Lipsovir(R) Has Entered Phase III Clinical Study
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 May 2006
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Biopharmaceuticals Drug Delivery
Return to NewsFeed  

 Additional items found! 40

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 40 additional stories matching:
shingles
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.